Date published: 2025-12-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

Thiamet G (CAS 1009816-48-1)

5.0(2)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
(3aR,5R,6S,7R,7aR)-2-(Ethylamino)-3a,6,7,7a-tetrahydro-5-(hydroxymethyl)-5H-pyrano[3,2-d]thiazole-6,7-diol
Application:
Thiamet G is a potent and selective O-GlcNAcase inhibitor
CAS Number:
1009816-48-1
Purity:
≥97%
Molecular Weight:
248.30
Molecular Formula:
C9H16N2O4S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Thiamet G is a potent and selective inhibitor of the enzyme O-GlcNAcase, which is involved in the post-translational modification of proteins by adding or removing N-acetylglucosamine (O-GlcNAc). This compound is widely used in the study of protein glycosylation processes and has been pivotal in elucidating the role of O-GlcNAcylation in various cellular functions and diseases. Researchers utilize Thiamet G to investigate how alterations in O-GlcNAcylation levels affect signal transduction, transcription, and the cell cycle, contributing to a deeper understanding of cellular regulation mechanisms. In neuroscience, Thiamet G aids in the exploration of the implications of O-GlcNAcylation in neurodegenerative diseases, as abnormal protein glycosylation is a characteristic feature in such disorders. Its application in basic biochemical research has also helped in the identification of proteins that undergo this modification and in the understanding of the dynamic nature of protein O-GlcNAcylation.


Thiamet G (CAS 1009816-48-1) References

  1. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.  |  Liu, F., et al. 2004. Proc Natl Acad Sci U S A. 101: 10804-9. PMID: 15249677
  2. A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo.  |  Yuzwa, SA., et al. 2008. Nat Chem Biol. 4: 483-90. PMID: 18587388
  3. Acute O-GlcNAcylation prevents inflammation-induced vascular dysfunction.  |  Hilgers, RH., et al. 2012. Am J Physiol Heart Circ Physiol. 303: H513-22. PMID: 22777418
  4. Thiamet-G-mediated inhibition of O-GlcNAcase sensitizes human leukemia cells to microtubule-stabilizing agent paclitaxel.  |  Ding, N., et al. 2014. Biochem Biophys Res Commun. 453: 392-7. PMID: 25268318
  5. O-GlcNAcylation enhances the invasion of thyroid anaplastic cancer cells partially by PI3K/Akt1 pathway.  |  Zhang, P., et al. 2015. Onco Targets Ther. 8: 3305-13. PMID: 26635480
  6. Thiamet G mediates neuroprotection in experimental stroke by modulating microglia/macrophage polarization and inhibiting NF-κB p65 signaling.  |  He, Y., et al. 2017. J Cereb Blood Flow Metab. 37: 2938-2951. PMID: 27864466
  7. O-GlcNAcylation promotes migration and invasion in human ovarian cancer cells via the RhoA/ROCK/MLC pathway.  |  Niu, Y., et al. 2017. Mol Med Rep. 15: 2083-2089. PMID: 28259907
  8. XBP1 (X-Box-Binding Protein-1)-Dependent O-GlcNAcylation Is Neuroprotective in Ischemic Stroke in Young Mice and Its Impairment in Aged Mice Is Rescued by Thiamet-G.  |  Jiang, M., et al. 2017. Stroke. 48: 1646-1654. PMID: 28487326
  9. O-GlcNAcylation alters the selection of mRNAs for translation and promotes 4E-BP1-dependent mitochondrial dysfunction in the retina.  |  Dierschke, SK., et al. 2019. J Biol Chem. 294: 5508-5520. PMID: 30733333
  10. Upregulated protein O-GlcNAcylation promoted functional and structural recovery of the contused spinal cord injury in rats by Thiamet-G treatment.  |  Liang, H., et al. 2019. Neurol Res. 41: 780-790. PMID: 31092134
  11. O-GlcNAcylation of light chain serine 12 mediates rituximab production doubled by thiamet G.  |  Kim, HY., et al. 2020. Bioprocess Biosyst Eng. 43: 863-875. PMID: 31980903
  12. Hyperglycemia Acutely Increases Cytosolic Reactive Oxygen Species via O-linked GlcNAcylation and CaMKII Activation in Mouse Ventricular Myocytes.  |  Lu, S., et al. 2020. Circ Res. 126: e80-e96. PMID: 32134364
  13. Osteoclast Differentiation Is Suppressed by Increased O-GlcNAcylation Due to Thiamet G Treatment.  |  Takeuchi, T., et al. 2020. Biol Pharm Bull. 43: 1501-1505. PMID: 32999159
  14. Protein O-GlcNAcylation Promotes Trophoblast Differentiation at Implantation.  |  Ruane, PT., et al. 2020. Cells. 9: PMID: 33036308
  15. REM Sleep Deprivation Impairs Learning and Memory by Decreasing Brain O-GlcNAc Cycling in Mouse.  |  Kim, SM., et al. 2021. Neurotherapeutics. 18: 2504-2517. PMID: 34312767
  16. Structure-based discovery and development of novel O-GlcNAcase inhibitors for the treatment of Alzheimer's disease.  |  Li, X., et al. 2022. Eur J Med Chem. 238: 114444. PMID: 35588599

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Thiamet G, 1 mg

sc-224307
1 mg
$51.00

Thiamet G, 5 mg

sc-224307A
5 mg
$94.00